Form 6-K NIO Inc. For: Mar 21

Go back to Form 6-K NIO Inc. For: Mar 21

Citi Reiterates Buy Rating on NIO (NIO)

March 25, 2025 10:27 AM EDT

Citi analyst Jeff Chung reiterated a Buy rating and $8.10 price target on NIO (NYSE: NIO).

The analyst comments "Cassava Sciences, Inc. (SAVA; Sell) announced topline results from the Phase 3 REFOCUS-ALZ study of simufilam in mild-to-moderate AD. Simufilam is a proprietary, investigational oral... More

NIO (NIO) PT Lowered to $4.90 at BofA Securities

March 21, 2025 2:40 PM EDT

BofA Securities analyst Ming Hsun Lee lowered the price target on NIO (NYSE: NIO) to $4.90 (from $5.00) while maintaining a Neutral rating.

The analyst comments "Management guided 41-43k units of vehicle delivery (+36% to +43% YoY) and RMB12.4- 12.9bn (+25% to +30% YoY). Accordingly, we raise our... More